Literature DB >> 22001450

Characteristics of Japanese patients with chronic gastritis and comparison with functional dyspepsia defined by ROME III criteria: based on the large-scale survey, FUTURE study.

Yoshikazu Kinoshita1, Tsutomu Chiba.   

Abstract

OBJECTIVE: To clarify the clinical characteristics of patients diagnosed with chronic gastritis in Japan, a large scale clinical survey of patients with chronic upper gastrointestinal symptoms was conducted. Patients diagnosed with functional dyspepsia (FD) according to the ROME III criteria were selected from among patients with chronic gastritis and the clinical characteristics of patients with FD and those with chronic gastritis were compared. PATIENTS AND METHODS: Patients with upper abdominal symptoms and diagnosed with chronic gastritis were enrolled in the study. Their main complaints, duration of symptoms, clinical characteristics, mental state, and results of endoscopic examinations, if available, were prospectively surveyed. Quality of life (QOL) impairment caused by abdominal symptoms was also surveyed using the Izumo QOL scale.
RESULTS: A total of 9,125 patients with a clinical diagnosis of chronic gastritis were enrolled in the survey. Of those, approximately 60% had more than 2 symptoms and QOL impairment was greater in cases with multiple symptoms. Endoscopic examinations were performed in 2,946 cases (32.3% of enrolled patients), during which gastric and/or esophageal carcinoma was found in only 0.2%, though organic diseases were found in 6.2%. Endoscopic examinations were not done for patients with high risks of organic diseases. Of patients with organic diseases excluded by an endoscopic examination, only 362 (12.3% of patients who underwent an endoscopy) were diagnosed with FD according to the ROME III criteria, mainly because of short symptom duration. There were no remarkable differences in regard to clinical characteristics, including symptoms and mental state, between patients with chronic gastritis and those with FD.
CONCLUSION: Clinical characteristics of patients with chronic gastritis were similar to those with FD, except for shorter symptom duration.

Entities:  

Mesh:

Year:  2011        PMID: 22001450     DOI: 10.2169/internalmedicine.50.5678

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  20 in total

1.  Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.

Authors:  Yoshikazu Kinoshita; Hiroto Miwa; Katsuyuki Sanada; Koji Miyata; Ken Haruma
Journal:  J Gastroenterol       Date:  2013-05-08       Impact factor: 7.527

2.  Evidence-based clinical practice guidelines for functional dyspepsia.

Authors:  Hiroto Miwa; Motoyasu Kusano; Tomiyasu Arisawa; Tadayuki Oshima; Mototsugu Kato; Takashi Joh; Hidekazu Suzuki; Kazunari Tominaga; Koji Nakada; Akihito Nagahara; Seiji Futagami; Noriaki Manabe; Akio Inui; Ken Haruma; Kazuhide Higuchi; Koji Yakabi; Michio Hongo; Naomi Uemura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2015-01-14       Impact factor: 7.527

3.  Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.

Authors:  Yoshikazu Kinoshita; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2011-12-21       Impact factor: 7.527

4.  Long-term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor-resistant gastroesophageal reflux disease.

Authors:  Satoshi Shinozaki; Hiroyuki Osawa; Yoshikazu Hayashi; Yoshimasa Miura; Alan Kawarai Lefor; Hironori Yamamoto
Journal:  Biomed Rep       Date:  2021-02-01

5.  A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.

Authors:  Mariko Hojo; Akihito Nagahara; Daisuke Asaoka; Tsutomu Takeda; Kentaro Izumi; Kohei Matsumoto; Hiroya Ueyama; Yuji Shimada; Kenshi Matsumoto; Shuko Nojiri; Sumio Watanabe
Journal:  Digestion       Date:  2017-06-13       Impact factor: 3.216

Review 6.  Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia.

Authors:  Hiroto Miwa
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

7.  A comparative study of the effects of daily minodronate and weekly alendronate on upper gastrointestinal symptoms, bone resorption, and back pain in postmenopausal osteoporosis patients.

Authors:  Toru Yoshioka; Nobukazu Okimoto; Ken Okamoto; Akinori Sakai
Journal:  J Bone Miner Metab       Date:  2012-10-19       Impact factor: 2.626

8.  Vonoprazan 10 mg daily is effective for the treatment of patients with proton pump inhibitor-resistant gastroesophageal reflux disease.

Authors:  Satoshi Shinozaki; Hiroyuki Osawa; Yoshikazu Hayashi; Hirotsugu Sakamoto; Yasutoshi Kobayashi; Alan Kawarai Lefor; Hironori Yamamoto
Journal:  Biomed Rep       Date:  2017-07-20

9.  Dose-Effect Relationship Between Gastric Cancer and Common Digestive Tract Symptoms and Diagnoses in Anhui, China.

Authors:  Mengsha Tang; Xingrong Shen; Jing Chai; Jing Cheng; Debin Wang
Journal:  Cancer Manag Res       Date:  2021-06-22       Impact factor: 3.602

10.  Investigating functional dyspepsia in Asia.

Authors:  Yeong Yeh Lee; Andrew Seng Boon Chua
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.